Alzheimer's disease (AD) is a neurodegenerative disorder that accounts for nearly 70% of
the more than 46 million dementia cases estimated worldwide. Although there is no cure for …

Background Cigarette smoking has been linked with both increased and decreased risk for
Alzheimer's disease (AD). This is relevant for the US military because the prevalence of …

Amyloid-β deposition in Alzheimer's disease is thought to start while individuals are still
cognitively unimpaired and it is hypothesized that after an early phase of fast accumulation …

Sleep disturbances, as well as sleep-wake rhythm disturbances, are typical symptoms of
Alzheimer's disease (AD) that may precede the other clinical signs of this neurodegenerative …

Alzheimer's disease (AD) is an increasingly prevalent, fatal neurodegenerative disease that
has proven resistant, thus far, to all attempts to prevent it, forestall it, or slow its progression …

The Precision Neurology development process implements systems theory with system
biology and neurophysiology in a parallel, bidirectional research path: a combined …

Mild cognitive impairment (MCI) has often been studied in its association with dementia, yet
higher rates of reversion to normal cognition than progression to dementia suggest that MCI …

Numerous studies have shown abnormal brain functional connectivity in individuals with
Alzheimer's disease (AD) or amnestic mild cognitive impairment (aMCI). However, most …

Normative modelling is an emerging method for quantifying how individuals deviate from the
healthy populational pattern. Several machine learning models have been implemented to …

Introduction Neuroinflammation and synaptic degeneration are major neuropathological
hallmarks in Alzheimer's disease (AD). Neurogranin and YKL-40 in cerebrospinal fluid …